7-74060495-G-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM5BP4_StrongBP6_Very_StrongBA1

The NM_000501.4(ELN):​c.1741G>C​(p.Gly581Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0854 in 1,614,208 control chromosomes in the GnomAD database, including 6,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G581E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.062 ( 422 hom., cov: 33)
Exomes 𝑓: 0.088 ( 6308 hom. )

Consequence

ELN
NM_000501.4 missense

Scores

2
8
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 3.24

Publications

37 publications found
Variant links:
Genes affected
ELN (HGNC:3327): (elastin) This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]
ELN-AS1 (HGNC:40212): (ELN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-74060495-GG-CA is described in ClinVar as Pathogenic. ClinVar VariationId is 1197278.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.006361991).
BP6
Variant 7-74060495-G-C is Benign according to our data. Variant chr7-74060495-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 177898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0941 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELNNM_000501.4 linkc.1741G>C p.Gly581Arg missense_variant Exon 25 of 33 ENST00000252034.12 NP_000492.2 P15502-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELNENST00000252034.12 linkc.1741G>C p.Gly581Arg missense_variant Exon 25 of 33 1 NM_000501.4 ENSP00000252034.7 P15502-2

Frequencies

GnomAD3 genomes
AF:
0.0621
AC:
9458
AN:
152208
Hom.:
421
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.0921
Gnomad AMR
AF:
0.0625
Gnomad ASJ
AF:
0.0757
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0604
Gnomad FIN
AF:
0.0383
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0960
Gnomad OTH
AF:
0.0750
GnomAD2 exomes
AF:
0.0698
AC:
17545
AN:
251396
AF XY:
0.0732
show subpopulations
Gnomad AFR exome
AF:
0.0166
Gnomad AMR exome
AF:
0.0485
Gnomad ASJ exome
AF:
0.0714
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.0486
Gnomad NFE exome
AF:
0.0991
Gnomad OTH exome
AF:
0.0851
GnomAD4 exome
AF:
0.0878
AC:
128382
AN:
1461882
Hom.:
6308
Cov.:
32
AF XY:
0.0877
AC XY:
63807
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0147
AC:
492
AN:
33480
American (AMR)
AF:
0.0515
AC:
2302
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0725
AC:
1894
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.0659
AC:
5683
AN:
86258
European-Finnish (FIN)
AF:
0.0521
AC:
2783
AN:
53420
Middle Eastern (MID)
AF:
0.0882
AC:
508
AN:
5762
European-Non Finnish (NFE)
AF:
0.0988
AC:
109811
AN:
1112008
Other (OTH)
AF:
0.0812
AC:
4903
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
9334
18668
28001
37335
46669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3892
7784
11676
15568
19460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0621
AC:
9457
AN:
152326
Hom.:
422
Cov.:
33
AF XY:
0.0578
AC XY:
4307
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0177
AC:
735
AN:
41594
American (AMR)
AF:
0.0625
AC:
956
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0757
AC:
263
AN:
3472
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5182
South Asian (SAS)
AF:
0.0609
AC:
294
AN:
4828
European-Finnish (FIN)
AF:
0.0383
AC:
407
AN:
10614
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0961
AC:
6533
AN:
68012
Other (OTH)
AF:
0.0733
AC:
155
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
453
906
1359
1812
2265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0722
Hom.:
162
Bravo
AF:
0.0613
TwinsUK
AF:
0.0982
AC:
364
ALSPAC
AF:
0.100
AC:
387
ESP6500AA
AF:
0.0197
AC:
87
ESP6500EA
AF:
0.0995
AC:
856
ExAC
AF:
0.0712
AC:
8638
Asia WGS
AF:
0.0290
AC:
102
AN:
3478
EpiCase
AF:
0.101
EpiControl
AF:
0.103

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 02, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gly581Arg in exon 25 of ELN: This variant is not expected to have clinical sig nificance because it has been identified in 9% (6470/66700) of European chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs17855988). -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Supravalvar aortic stenosis Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis laxa, autosomal dominant 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis laxa, autosomal dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T;T;.;D;T;.;.;.;.;T;.;.;.;.;.
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.53
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0064
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
.;.;.;L;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
3.2
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-4.6
D;.;D;.;D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
0.29
Sift
Pathogenic
0.0
D;.;D;.;D;D;.;D;D;D;D;D;.;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;.;D;D;D;D;D;D;D;D;D;D;.
Vest4
0.90
MutPred
0.40
.;.;.;.;.;.;.;.;.;Gain of methylation at G571 (P = 0.0126);.;.;.;.;.;
MPC
0.22
ClinPred
0.041
T
GERP RS
3.5
Varity_R
0.11
gMVP
0.64
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17855988; hg19: chr7-73474825; COSMIC: COSV52710379; COSMIC: COSV52710379; API